Cargando…

Advances in post-translational modifications of proteins and cancer immunotherapy

Protein post-translational modification (PTM) is a regulatory mechanism for protein activity modulation, localization, expression, and interactions with other cellular molecules. It involves the addition or removal of specific chemical groups on the amino acid residues of proteins. Its common forms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yanqing, Zhang, Runfang, Hei, Hu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477431/ https://www.ncbi.nlm.nih.gov/pubmed/37675097 http://dx.doi.org/10.3389/fimmu.2023.1229397

Ejemplares similares

Editorial: Post-translational modifications of proteins in cancer immunity and immunotherapy
por: Dai, Xiangpeng, et al.
Publicado: (2022)

Regulation of post-translational modification of PD-L1 and advances in tumor immunotherapy
por: Feng, Chong, et al.
Publicado: (2023)

Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume II
por: Nihira, Naoe Taira, et al.
Publicado: (2023)

Post-Translational Modifications of Exosomal Proteins
por: Moreno-Gonzalo, Olga, et al.
Publicado: (2014)

Post-translational modifications and immune responses in liver cancer
por: Wang, You-Wei, et al.
Publicado: (2023)

Editorial: Targeting Protein Post-Translational Modifications (PTMs) for Diagnosis and Treatment of Sepsis
por: Chang, Panpan, et al.
Publicado: (2022)

Protein post-translational modification in SARS-CoV-2 and host interaction
por: Cheng, Nana, et al.
Publicado: (2023)

Post-Translational Modifications of Proteins in Cytosolic Nucleic Acid Sensing Signaling Pathways
por: Deng, Yu, et al.
Publicado: (2022)

Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy
por: Dai, Weijing, et al.
Publicado: (2022)

Role of Histone Post-Translational Modifications in Inflammatory Diseases
por: Lin, Yingying, et al.
Publicado: (2022)

Foxp3 Post-translational Modifications and Treg Suppressive Activity
por: Deng, Guoping, et al.
Publicado: (2019)

Post-Translational Modifications of STING: A Potential Therapeutic Target
por: Kang, Jiaqi, et al.
Publicado: (2022)

Dysbiosis May Trigger Autoimmune Diseases via Inappropriate Post-Translational Modification of Host Proteins
por: Lerner, Aaron, et al.
Publicado: (2016)

The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment
por: De Sanctis, Francesco, et al.
Publicado: (2014)

Toward Understanding the Essence of Post-Translational Modifications for the Mycobacterium tuberculosis Immunoproteome
por: van Els, Cécile A. C. M., et al.
Publicado: (2014)

Immunological Significance of HMGB1 Post-Translational Modification and Redox Biology
por: Kwak, Man Sup, et al.
Publicado: (2020)

Post-translational Modification Regulates Formation and Cargo-Loading of Extracellular Vesicles
por: Carnino, Jonathan M., et al.
Publicado: (2020)

Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules
por: Seok, Jin Kyung, et al.
Publicado: (2021)

Identification of autoantigens and their potential post-translational modification in EGPA and severe eosinophilic asthma
por: Esposito, Ilaria, et al.
Publicado: (2023)

Interplay between metabolic reprogramming and post-translational modifications: from glycolysis to lactylation
por: Wu, Hengwei, et al.
Publicado: (2023)

Post translational modification-assisted cancer immunotherapy for effective breast cancer treatment
por: Theivendran, Shevanuja, et al.
Publicado: (2020)

Oxidation is an underappreciated post-translational modification in the regulation of immune responses associated with changes in phosphorylation
por: Karkossa, Isabel, et al.
Publicado: (2023)

Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications
por: Jadeja, Shahnawaz D., et al.
Publicado: (2022)

Editorial: Post-translational modifications of extracellular signaling molecules and antigens in immune and inflammatory responses
por: Afonina, Inna S., et al.
Publicado: (2022)

Editorial: Translation of genetically engineered T cells in cancer immunotherapy
por: Voss, Ralf-Holger, et al.
Publicado: (2023)

Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy
por: Ding, Peng, et al.
Publicado: (2022)

Post-translational modifications confer amphotericin B resistance in Candida krusei isolated from a neutropenic patient
por: Zhang, Li, et al.
Publicado: (2023)

Cancer immunotherapies: advances and bottlenecks
por: Rui, Rui, et al.
Publicado: (2023)

Post-translational Modifications of the Protein Termini
por: Chen, Li, et al.
Publicado: (2021)

Protein Post-translational Modifications in Head and Neck Cancer
por: Zhang, Hongbo, et al.
Publicado: (2020)

Editorial: Structure, Isotypes, Targets, and Post-translational Modifications of Immunoglobulins and Their Role in Infection, Inflammation and Autoimmunity
por: Harb, Jean, et al.
Publicado: (2020)

Post-translational modifications on the retinoblastoma protein
por: Zhou, Linbin, et al.
Publicado: (2022)

Roles and therapeutic implications of m6A modification in cancer immunotherapy
por: Pan, Juan, et al.
Publicado: (2023)

Targeting post-translational modifications of Foxp3: a new paradigm for regulatory T cell-specific therapy
por: Riaz, Farooq, et al.
Publicado: (2023)

Advances on Post-translational Modifications Involved in Seed Germination
por: Yu, Feng, et al.
Publicado: (2021)

Post-translational protein modifications in schizophrenia
por: Mueller, Toni M., et al.
Publicado: (2020)

Editorial: Translational phenomics and its applications in immunotherapy
por: Fang, Hai, et al.
Publicado: (2023)

The post-translational modification, SUMOylation, and cancer (Review)
por: Han, Zhi-Jian, et al.
Publicado: (2018)

Editorial: Structure, isotypes, targets, and post-translational modifications of immunoglobulins and their role in infection, inflammation and autoimmunity, Volume II
por: Novak, Jan, et al.
Publicado: (2022)

Emerging role of deubiquitination modifications of programmed death-ligand 1 in cancer immunotherapy
por: Jiang, Yao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qk5kre1dc46iu9s4sn9abhqr5n